Shoulder Innovations (SI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
29 Apr, 2026Executive summary
The annual meeting will be held virtually on June 26, 2026, with shareholders able to vote electronically or by phone using a control number.
Shareholders are asked to vote on the election of two Class I directors and the ratification of Deloitte & Touche LLP as the independent auditor for 2026.
The company is classified as an emerging growth company and follows reduced public company reporting requirements.
Forward-looking statements are included, subject to risks detailed in the annual report and SEC filings.
Voting matters and shareholder proposals
Proposal 1: Election of Robert Ball and Andrew Hykes as Class I directors for a three-year term.
Proposal 2: Ratification of Deloitte & Touche LLP as independent registered public accounting firm for 2026.
Board recommends voting FOR both proposals.
Shareholders may submit proposals for the 2027 meeting between December 30, 2026, and March 28, 2027, depending on meeting date.
Board of directors and corporate governance
Board consists of seven members post-meeting, with a staggered three-class structure.
Majority of directors are independent per NYSE rules; CEO and COO are not independent.
Board committees (Audit, Compensation, Nominating and Corporate Governance) are fully independent.
Lead Independent Director role established to enhance board accountability.
Corporate Governance Guidelines and Code of Ethics are in place and overseen by the Audit Committee.
Latest events from Shoulder Innovations
- Vote on director elections and auditor ratification at the June 26, 2026 annual meeting.SI
Proxy filing29 Apr 2026 - Q4 revenue up 65% and 2026 guidance targets 31–37% growth, driven by innovation and ASC momentum.SI
Q4 202510 Mar 2026 - Innovative implants and AI-driven planning fuel rapid growth and high margins in shoulder arthroplasty.SI
Investor presentation10 Mar 2026 - AI-driven innovation and outpatient focus fuel strong growth and new opportunities in shoulder arthroplasty.SI
2026 CG Musculoskeletal Conference4 Mar 2026 - Disruptive InSet Glenoid and AI-driven platform fuel rapid growth in shoulder arthroplasty.SI
Investor presentation3 Mar 2026 - AI-driven planning and streamlined implants drive growth as ASC adoption accelerates.SI
Jefferies London Healthcare Conference 20253 Feb 2026 - 33% Q2 growth fueled by efficient two-tray system, ASC focus, and commercial scaling.SI
Morgan Stanley 23rd Annual Global Healthcare Conference31 Dec 2025 - Portable robotics and surgeon-focused innovation fuel rapid growth and strong margins.SI
Piper Sandler 37th Annual Healthcare Conference13 Dec 2025 - IPO seeks $88M to scale shoulder implant business, fund R&D, and expand in a competitive market.SI
Registration Filing29 Nov 2025